Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Circulation

• Publication date

  2011-10-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.110.008870PMID 21947289
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

  2011cited by this paper
• Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.

  2010cited by this paper
• Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension.

  2010cited by this paper
• Effects of intensive blood-pressure control in type 2 diabetes mellitus.

  2010cited by this paper
• Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

  2010cited by this paper
• Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis.

  2010cited by this paper
• Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study

  2009cited by this paper
• When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal

  2009cited by this paper
• Lowering blood pressure reduces renal events in type 2 diabetes.

  2009cited by this paper
• Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study

  2009cited by this paper
• Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.

  2009cited by this paper
• Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

  2009cited by this paper
• Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes.

  2009cited by this paper
• Telmisartan, ramipril, or both in patients at high risk for vascular events.

  2008cited by this paper
• Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

  2007cited by this paper
• Mellitus: A Scientific Statement From the American Heart Association and the Primary Prevention of Cardiovascular Diseases in People With Diabetes

  2007cited by this paper
• Blood Pressure Control and Improved Cardiovascular Outcomes in the International Verapamil SR-Trandolapril Study

  2007cited by this paper
• Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary

  2007cited by this paper
• Guidelines on Diabetes, Pre-Diabetes, and Cardiovascular Diseases: Executive Summary

  2007cited by this paper
• Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system

  2007cited by this paper
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

  2007cited by this paper
• Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus

  2006cited by this paper
• Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE Study

  2006cited by this paper
• Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous?

  2006cited by this paper
• The Epidemiology of Stroke in the East Asian Region: A Literature-Based Review

  2006cited by this paper
• Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial

  2006cited by this paper
• Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*

  2006cited by this paper
• Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy

  2004cited by this paper
• Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.

  2003cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

  2003cited by this paper
• Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

  2003cited by this paper
• European guidelines on cardiovascular disease prevention in clinical practice; Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)

  2003cited by this paper
• European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

  2003cited by this paper
• Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack.

  2003cited by this paper
• Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002)

  2003cited by this paper
• Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

  2002cited by this paper
• Systolic and diastolic blood pressure control in antihypertensive drug trials.

  2002cited by this paper
• Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

  2001cited by this paper
• Cardiovascular protection and blood pressure reduction: a meta-analysis.

  2001cited by this paper
• Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

  2000cited by this paper
• Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study.

  1999cited by this paper
• Post-stroke antihypertensive treatment study. A preliminary result.

  1995cited by this paper
• Upward Shift of the Lower Range of Coronary Flow Autoregulation in Hypertensive Patients With Hypertrophy of the Left Ventricle

  1991cited by this paper
• Cerebral blood flow in patients with congestive heart failure treated with captopril.

  1984cited by this paper
• The renal circulation.

  1951cited by this paper

• Preventive and Therapeutic Effects of Sericin-Derived Oligopeptides (SDOs) from Yellow Silk Cocoons on Blood Pressure Lowering in L-NAME-Induced Hypertensive Rats

  2025cites this paper
• Efficacy of renin-angiotensin system inhibitors, calcium channel blockers, and diuretics in hypertensive patients with diabetes: subgroup analysis based on albuminuria in a systematic review and meta-analysis

  2025cites this paper
• Revisiting Cardiovascular Benefits of Blood Pressure Reduction in Primary and Secondary Prevention: Focus on Targets and Residual Risk—A Systematic Review and Meta-Analysis

  2024cites this paper
• Impact of seasonal blood pressure changes on visit-to-visit blood pressure variability and related cardiovascular outcomes

  2024cites this paper
• Association Between Systolic Blood Pressure and in-Hospital Mortality Among Congestive Heart Failure Patients with Chronic Obstructive Pulmonary Disease in the Intensive Care Unit: A Retrospective Cohort Study

  2024cites this paper
• Pharmacological Nephroprotection in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus—Clinical Practice Position Statement of the Polish Society of Nephrology

  2024cites this paper
• Comparison between visit-to-visit office and 24-h blood pressure variability in treated hypertensive patients

  2023cites this paper
• Perspectives on improving blood pressure control to reduce the clinical and economic burden of hypertension

  2023cites this paper
• Middle-Aged and Older Patients With Left Ventricular Hypertrophy: Higher Mortality With Drug Treated Systolic Blood Pressure Below 130 mm Hg

  2023cites this paper
• Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.

  2023cites this paper
• 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH).

  2023cites this paper
• Causal associations between blood pressure and the risk of myocardial infarction: A bidirectional Mendelian randomization study

  2022cites this paper
• Blood Pressure Control Targets and Risk of Cardiovascular and Cerebrovascular Events After Intracerebral Hemorrhage

  2022cites this paper
• High Prevalence of Primary Aldosteronism in Patients with Type 2 Diabetes Mellitus and Hypertension

  2022cites this paper
• The debate over the optimal blood pressure treatment target of less than 130/80 mmHg

  2022cites this paper
• Admission Systolic Blood Pressure and In-hospital Mortality in Acute Type A Aortic Dissection: A Retrospective Observational Study

  2021cites this paper
• Telmisartan Attenuates the Growth of Epithelium-like Cells and Glomerular Injury in Spontaneously Hypertensive Rats

  2021cites this paper
• Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus compared to all middle-aged and elderly hypertensive study patients with high cardiovascular risk

  2021cites this paper
• Circulation: Cardiovascular Quality and Outcomes

  2021cites this paper
• Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus and hypertension

  2021cites this paper
• Polypharmacy in the Management of Arterial Hypertension—Friend or Foe?

  2021cites this paper
• The Diastolic Blood Pressure J-Curve in Hypertension Management: Links and Risk for Cardiovascular Disease

  2021cites this paper
• Using Restricted Cubic Splines to Study the Trajectory of Systolic Blood Pressure in the Prognosis of Acute Myocardial Infarction

  2021cites this paper
• Diabetes mellitus and arterial hypertension

  2021cites this paper
• Tight versus standard blood pressure control on the incidence of myocardial infarction and stroke: an observational retrospective cohort study in the general ambulatory setting

  2020cites this paper
• Prevalence of hypotension in hypertensive treated patients within the Primary Care setting. The PRESCAP 2010 study.

  2020cites this paper
• Blood pressure and heart failure

  2020cites this paper
• Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials.

  2020cites this paper
• A koszorúér-betegség előfordulása kezelt hipertóniában a vérnyomásértékek függvényében. Magyar Hipertónia Regiszter 2011–2013–2015

  2020cites this paper
• Heart Failure as a Consequence of Hypertension

  2020cites this paper
• Sodium-Glucose Cotransporter-2 Inhibitors, Reverse J-Curve Pattern, and Mortality in Heart Failure.

  2019cites this paper
• Two-Drug Combinations as First-Step Antihypertensive Treatment.

  2019cites this paper
• Cohort Study Examining the Association Between Blood Pressure and Cardiovascular Events in Patients With Peripheral Artery Disease

  2019cites this paper
• Importance of diastolic arterial pressure in septic shock: PRO.

  2019cites this paper
• PREDICTORS OF ARTERIAL HYPERTENSION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN AZERBAIJAN POPULATION

  2019cites this paper
• Guía ESC/ESH 2018 sobre el diagnóstico y tratamiento de la hipertensión arterial

  2019cites this paper
• Individual shear rate therapy (ISRT)—further development of external counterpulsation for decreasing blood pressure in patients with symptomatic coronary artery disease (CAD)

  2019cites this paper
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2018cites this paper
• 50 – Updated American Heart Association/American College of Cardiology; European Society of Hypertension/International Society of Hypertension Guidelines

  2018cites this paper
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2018cites this paper
• Aggressive systolic blood pressure control in older subjects: benefits and risks

  2018cites this paper
• 2018 ESC/ESH Guidelines for the management of arterial hypertension.

  2018cites this paper
• Association between mean systolic and diastolic blood pressure throughout the follow‐up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High‐Risk Myocardial Infarction Database Initiative

  2018cites this paper
• Target blood pressure and kidney protection.

  2018cites this paper
• Hypertension in patients with type 2 diabetes mellitus: Targets and management.

  2018cites this paper
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2018cites this paper
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2018cites this paper
• Drug treatment of hypertension in older patients with diabetes mellitus

  2018cites this paper
• Novel Hypertension Management Model of Care Improves Blood Pressure Control in a West African Population

  2018cites this paper
• Is there a risk in overtreating a hypertensive patient?

  2017cites this paper
• Effect of diabetes and metabolic syndrome on myocardial mechano-energetic efficiency in hypertensive patients. The Campania Salute Network

  2017cites this paper
• Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial

  2017cites this paper
• Blood Pressure Variability and its Significance

  2017cites this paper
• Oxidative imbalance and kidney damage in spontaneously hypertensive rats: activation of extrinsic apoptotic pathways.

  2017cites this paper
• Effects of reducing blood pressure on renal outcomes in patients with type 2 diabetes: Focus on SGLT2 inhibitors and EMPA-REG OUTCOME.

  2017cites this paper
• Cardiovascular Event Rates and Mortality According to Achieved Systolic and Diastolic Blood Pressure in Patients With Stable Coronary Artery Disease: An International Cohort Study

  2017cites this paper
• Achieving blood pressure targets for prolonged cardiovascular health: a historical perspective

  2017cites this paper
• Clinical hypertension - from early prediction to prevalence, treatment adherence and outcome of resistant hypertension

  2017cites this paper
• The J-shaped Curve for Blood Pressure and Cardiovascular Disease Risk: Historical Context and Recent Updates

  2017cites this paper
• New evidence for the diastolic J‐curve effect challenges the safety of intensive blood pressure control

  2017cites this paper
• Decreased systolic blood pressure is associated with increased risk of all-cause mortality in patients with type 2 diabetes and renal impairment: A nationwide longitudinal observational study of 27,732 patients based on the Swedish National Diabetes Register

  2017cites this paper
• Optimal Systolic Blood Pressure Levels for Primary Prevention of Stroke in General Hypertensive Adults: Findings From the CSPPT (China Stroke Primary Prevention Trial)

  2017cites this paper
• Blood pressure control and cardiovascular risk in hypertensive patients with type 2 diabetes: The German T2Target registry

  2017cites this paper
• Selecting Optimum Antihypertensive Therapy

  2016cites this paper
• Specific Blood Pressure Targets for Patients With Diabetic Nephropathy?

  2016cites this paper
• Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.

  2016cites this paper
• 7th Brazilian Guideline of Arterial Hypertension: Chapter 8 - Hypertension and Associated Clinical Conditions

  2016cites this paper
• Longitudinal Patterns of Blood Pressure, Incident Cardiovascular Events, and All-Cause Mortality in Normotensive Diabetic People

  2016cites this paper
• Depressed myocardial energetic efficiency is associated with increased cardiovascular risk in hypertensive left ventricular hypertrophy

  2016cites this paper
• The impact of SPRINT on the future treatment of hypertension: a mini review.

  2016cites this paper
• Impact of Empagliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive Medication

  2016cites this paper
• Is there a J-curve for hypertension and cardiovascular disease ?

  2016cites this paper
• MANEJO DE LA HIPERTENSIÓN ARTERIAL EN DIABETES MELLITUS

  2016cites this paper
• El tratamiento de la hipertensión arterial sistémica en pacientes con enfermedad arterial coronaria

  2016cites this paper
• Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.

  2016cites this paper
• 7TH BRAZILIAN GUIDELINE OF ARTERIAL HYPERTENSION

  2016cites this paper
• Hypotension based on office and ambulatory monitoring blood pressure. Prevalence and clinical profile among a cohort of 70,997 treated hypertensives.

  2016cites this paper
• Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension

  2015cites this paper
• Blood pressure level and risk of major cardiovascular events and all-cause of mortality in patients with type 2 diabetes and renal impairment: an observational study from the Swedish National Diabetes Register

  2015cites this paper
• Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology

  2015cites this paper
• Blood pressure target goals from guidelines of 2002-2014.

  2015cites this paper
• Newer targets and therapies for hypertension and dyslipidemia in diabetic patients

  2015cites this paper
• Lipids, blood pressure and kidney update 2015

  2015cites this paper
• Medizinische Universitätsklinik, Kantonsspital Baselland, Liestal

  2015cites this paper
• Systolic BP and Mortality in Older Adults with CKD.

  2015cites this paper
• ¿CUÁNTO TIENE LA PREDIABETES DE PRE-DIABETES?

  2015cites this paper
• Organ Damage and Blood Pressure in Untreated and Treated Hypertensives

  2015cites this paper
• Effect of non-antihypertensive drugs on endothelial function in hypertensive subjects evaluated by flow-mediated vasodilation.

  2015cites this paper
• New threshold and target blood pressures in the hypertension guidelines. Which implications for the hypertensive population?

  2015cites this paper
• Treating hypertension and prehypertension in older people: when, whom and how.

  2015cites this paper
• Blood Pressure Goals and Targets in the Elderly

  2015cites this paper
• [The Results of Long-Term Observation of Patients Who Participated in the ADVANCE Trial].

  2015cites this paper
• Blood Pressure Control versus Atrial Fibrillation Management in Stroke Prevention

  2015cites this paper
• Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.

  2015cites this paper
• Lipids, blood pressure and kidney update 2015

  2015cites this paper
• [Blood pressure limits--the lower, the better?].

  2015cites this paper
• Antihypertensive combination therapy in primary care offices: results of a cross-sectional survey in Switzerland

  2014cites this paper
• Prevention of cardiovascular disease and diabetes on a population level

  2014cites this paper
• What Should the Systolic Blood Pressure Treatment Goal Be in Patients Aged 60 Years and Older with Hypertension?

  2014cites this paper
• Aggressive blood pressure lowering is dangerous: the J-curve: pro side of the arguement.

  2014cites this paper